The ability to engineer EVs and the ability of EVs to target specific sites offers the ability to tailor therapeutics with "exquisite targeting ability" and opens up a whole new class of therapeutics which are classified as biologicals and which do not have the side effects and toxicity associated with small molecule-based therapies